Access cutting-edge chronic lymphocytic leukemia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access chronic lymphocytic leukemia specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic lymphocytic leukemia treatment provided free
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this chronic lymphocytic leukemia clinical trial in Chicago, IL
If you're searching for chronic lymphocytic leukemia treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.